Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Current Opinion in Gastroenterology|April 8, 2009
Cholangiociliopathies: genetics, molecular mechanisms and potential therapiesTatyana Masyuk, Anatoliy Masyuk, Nicholas LaRussoMethods in Cell Biology|April 6, 2010
Isolation of primary cilia for morphological analysisBing Huang, Tatyana Masyuk, Nicholas LaRussoCell Cycle (Georgetown, Tex.)|April 4, 2009
MicroRNAs in cholangiociliopathiesTatyana Masyuk, Anatoliy Masyuk, Nicholas LaRussoJournal of Clinical Medicine|September 8, 2015
MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and TreatmentMaria Jose Lorenzo Pisarello, Lorena Loarca, Tommy Ivanics, et al.Digestive Diseases and Sciences|September 1, 2005
The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitisCynthia Levy, James Lymp, Paul Angulo, et al.The American Journal of Pathology|January 23, 2010
Hepato-renal pathology in pkd2ws25/- mice, an animal model of autosomal dominant polycystic kidney diseaseAngela Stroope, Brynn Radtke, Bing Huang, et al.JHEP Reports : Innovation in Hepatology|September 27, 2021
Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver diseaseTatyana Masyuk, Anatoliy Masyuk, Christy Trussoni, et al.The Journal of Clinical Investigation|October 25, 2008
MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney diseaseSeung-Ok Lee, Tatyana Masyuk, Patrick Splinter, et al.Cancer Detection and Prevention|November 16, 2004
Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinomaTakashi Maeda, Ken-ichi Taguchi, Shin-ichi Aishima, et al.Journal of Gastroenterology and Hepatology|February 14, 2026
Plasma Biomarkers of Senescence in Cholestatic Liver Disease: A Signature of Risk Stratification and ProgressionSteven P O'Hara, Pamela Tietz Bogert, Stephanie Dickinson, et al.Pageof 2